TEWKSBURY, Mass.–(BUSINESS WIRE)–Cambridge Heart, Inc. (OTCBB: CAMH), a developer of non-invasive diagnostic tests for cardiac disease, today announced that its HearTwave II System was cleared for sale by the Mexican regulatory authorities. In August 2010, the Company executed an exclusive distribution agreement with Mayerick S.A. de S.V. to distribute the HearTwave II System, including the Company’s proprietary Microvolt T-Wave Alternans™ (MTWA) software and Micro-V Alternans Sensors.